139 related articles for article (PubMed ID: 1399387)
1. Primary chemotherapy in the management of low stage (IIA and IIB) non-seminomatous germ cell testicular tumours.
Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V
Int Urol Nephrol; 1992; 24(3):299-304. PubMed ID: 1399387
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of testicular cancer: 10-year experience.
Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
[TBL] [Abstract][Full Text] [Related]
3. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
Culine S; Theodore C; Court BH; Perrin JL; Droz JP
Br J Urol; 1997 Feb; 79(2):258-62. PubMed ID: 9052479
[TBL] [Abstract][Full Text] [Related]
5. [Effects of chemotherapy on regional metastases of non-seminomatous tumors of the testis].
Sakalo VS; Romanenko AM; Klimenko IA; Persidskiĭ IuV
Vopr Onkol; 1988; 34(10):1219-24. PubMed ID: 3188424
[TBL] [Abstract][Full Text] [Related]
6. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Sparwasser C; Treiber U; Beckert R; Pust RA
Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
[TBL] [Abstract][Full Text] [Related]
7. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
8. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
Taylor RE; Duncan W; Davey P; Munro AJ; Cornbleet MA
Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
[TBL] [Abstract][Full Text] [Related]
10. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of testicular germ cell tumors. Current status of the MAHO studies].
Haas RJ; Schmidt P; Göbel U; Harms D
Klin Padiatr; 1993; 205(4):225-30. PubMed ID: 8397320
[TBL] [Abstract][Full Text] [Related]
12. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.
Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J
J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer.
Pizzocaro G; Pasi M; Salvioni R; Zanoni F; Milani A; Piva L
Cancer; 1985 Nov; 56(10):2399-403. PubMed ID: 2412681
[TBL] [Abstract][Full Text] [Related]
14. The growing teratoma syndrome.
Jeffery GM; Theaker JM; Lee AH; Blaquiere RM; Smart CJ; Mead GM
Br J Urol; 1991 Feb; 67(2):195-202. PubMed ID: 2004236
[TBL] [Abstract][Full Text] [Related]
15. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
16. No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Monfardini S
J Urol; 1984 Apr; 131(4):677-80. PubMed ID: 6200611
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis.
Kulkarni RP; Reynolds KW; Newlands ES; Dawson PM; Makey AR; Theodorou NA; Bradley J; Begent RH; Rustin GJ; Bagshawe KD
Br J Surg; 1991 Feb; 78(2):226-9. PubMed ID: 1707715
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
19. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
20. Late recurrence of mature teratoma in nonseminomatous testicular tumors after PVB chemotherapy and surgery.
Gelderman WA; Scraffordt Koops H; Sleijfer DT; Oosterhuis JW; Oldhoff J
Urology; 1989 Jan; 33(1):10-4. PubMed ID: 2463704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
